| Code | Description | Claims | Beneficiaries | Total Paid |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
135,848 |
125,854 |
$56.30M |
| G0378 |
Hospital observation service, per hour |
40,602 |
34,490 |
$45.01M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
78,442 |
71,407 |
$38.48M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
54,077 |
46,582 |
$24.95M |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
15,029 |
14,409 |
$18.85M |
| OP250 |
|
221,978 |
161,937 |
$9.96M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
35,279 |
33,659 |
$9.69M |
| 93303 |
Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study |
8,399 |
8,181 |
$9.54M |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
3,723 |
3,519 |
$6.87M |
| 93320 |
|
9,715 |
9,410 |
$6.67M |
| 93325 |
|
12,533 |
12,052 |
$6.28M |
| S9480 |
Intensive outpatient psychiatric services, per diem |
8,231 |
7,002 |
$5.97M |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
1,859 |
1,792 |
$5.36M |
| H0035 |
Mental health partial hospitalization, treatment, less than 24 hours |
18,246 |
1,700 |
$4.01M |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
54,743 |
49,647 |
$3.35M |
| OP370 |
|
27,651 |
25,442 |
$3.13M |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
6,976 |
3,675 |
$3.12M |
| 76818 |
|
12,262 |
5,713 |
$3.04M |
| 76819 |
Fetal biophysical profile; without non-stress testing |
13,750 |
10,111 |
$2.95M |
| 11043 |
|
3,586 |
1,876 |
$2.91M |
| 80053 |
Comprehensive metabolic panel |
116,532 |
94,875 |
$2.63M |
| 41899 |
Unlisted procedure, dentoalveolar structures |
1,109 |
1,076 |
$2.44M |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
1,201 |
1,160 |
$1.94M |
| 96375 |
Therapeutic injection; each additional sequential IV push |
29,823 |
22,711 |
$1.93M |
| 95813 |
|
2,950 |
2,902 |
$1.86M |
| 36430 |
|
3,234 |
2,469 |
$1.84M |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
42,738 |
37,551 |
$1.83M |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
16,887 |
15,297 |
$1.74M |
| 71046 |
Radiologic examination, chest; 2 views |
27,110 |
25,064 |
$1.74M |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
10,275 |
9,086 |
$1.69M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
9,213 |
8,452 |
$1.62M |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
69,180 |
55,459 |
$1.61M |
| OP710 |
|
18,915 |
17,495 |
$1.57M |
| 94760 |
|
15,898 |
15,019 |
$1.55M |
| 54161 |
|
637 |
621 |
$1.51M |
| 93458 |
|
1,136 |
962 |
$1.47M |
| 95811 |
|
518 |
495 |
$1.44M |
| 96361 |
Intravenous infusion, hydration; each additional hour |
26,244 |
22,375 |
$1.42M |
| 87902 |
|
11,648 |
10,571 |
$1.39M |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
4,620 |
2,187 |
$1.38M |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
29,898 |
7,703 |
$1.36M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
18,432 |
16,608 |
$1.36M |
| 42820 |
Tonsillectomy and adenoidectomy; younger than age 12 |
843 |
806 |
$1.35M |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
922 |
881 |
$1.33M |
| 71045 |
Radiologic examination, chest; single view |
22,691 |
19,504 |
$1.30M |
| OP272 |
|
27,925 |
24,574 |
$1.20M |
| 36415 |
Collection of venous blood by venipuncture |
164,438 |
125,623 |
$1.12M |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
4,067 |
4,013 |
$1.10M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
11,177 |
10,435 |
$1.07M |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
936 |
800 |
$1.04M |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
115,560 |
95,554 |
$1.04M |
| 93017 |
|
2,185 |
1,977 |
$984K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
1,956 |
1,841 |
$983K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
4,878 |
4,796 |
$976K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
10,946 |
10,796 |
$975K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
9,116 |
7,735 |
$966K |
| J9271 |
Injection, pembrolizumab, 1 mg |
218 |
133 |
$966K |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
634 |
607 |
$931K |
| 11046 |
|
1,373 |
708 |
$923K |
| 93970 |
|
2,750 |
2,533 |
$918K |
| 92587 |
|
3,881 |
3,828 |
$896K |
| 76820 |
|
5,911 |
2,970 |
$883K |
| 11045 |
|
1,191 |
521 |
$862K |
| 70450 |
Computed tomography, head or brain; without contrast material |
9,729 |
8,831 |
$839K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
9,218 |
8,758 |
$814K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
35,408 |
30,972 |
$808K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
38,394 |
33,303 |
$796K |
| 96409 |
|
1,807 |
1,028 |
$779K |
| P9016 |
Red blood cells, leukocytes reduced, each unit |
2,795 |
2,242 |
$749K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
5,754 |
5,576 |
$737K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
19,853 |
19,072 |
$736K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
10,530 |
10,405 |
$721K |
| 94729 |
|
3,307 |
3,067 |
$695K |
| 94060 |
|
2,157 |
2,036 |
$694K |
| 94010 |
|
3,137 |
2,424 |
$671K |
| OP258 |
|
71,723 |
54,215 |
$669K |
| 90791 |
Psychiatric diagnostic evaluation |
7,284 |
6,534 |
$663K |
| 95782 |
|
231 |
228 |
$656K |
| 92579 |
|
2,579 |
2,557 |
$628K |
| 76801 |
|
6,602 |
5,975 |
$617K |
| 90837 |
Psychotherapy, 53 minutes with patient |
8,447 |
5,479 |
$612K |
| 82962 |
|
48,625 |
37,610 |
$607K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
2,650 |
2,441 |
$586K |
| 90834 |
Psychotherapy, 45 minutes with patient |
10,793 |
7,296 |
$582K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
683 |
651 |
$578K |
| 96415 |
|
1,986 |
1,179 |
$570K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
1,620 |
1,449 |
$566K |
| 78815 |
Positron emission tomography (PET) for limited area imaging |
376 |
341 |
$565K |
| J2426 |
Injection, paliperidone palmitate extended release (invega sustenna), 1 mg |
700 |
654 |
$545K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
10,322 |
9,885 |
$541K |
| 75574 |
|
1,898 |
1,683 |
$534K |
| 92567 |
|
4,913 |
4,840 |
$524K |
| 96367 |
|
3,119 |
2,052 |
$493K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
3,726 |
3,412 |
$485K |
| 94618 |
|
2,206 |
1,921 |
$484K |
| 76825 |
|
1,603 |
1,588 |
$483K |
| 76830 |
Ultrasound, transvaginal |
3,600 |
3,511 |
$477K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
9,790 |
9,038 |
$476K |
| 76770 |
|
3,325 |
3,270 |
$468K |
| 71250 |
|
2,251 |
2,046 |
$465K |
| 58558 |
|
208 |
205 |
$456K |
| 86850 |
|
23,099 |
20,111 |
$456K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
9,964 |
9,140 |
$454K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
18,838 |
16,734 |
$434K |
| OP278 |
|
1,705 |
1,642 |
$433K |
| 76827 |
|
1,641 |
1,616 |
$422K |
| 90832 |
Psychotherapy, 30 minutes with patient |
7,804 |
5,551 |
$418K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
4,642 |
4,350 |
$417K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
9,213 |
8,396 |
$407K |
| 96417 |
|
1,674 |
993 |
$402K |
| 81220 |
CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants |
1,401 |
1,372 |
$391K |
| 76642 |
|
3,040 |
2,929 |
$386K |
| 92557 |
|
1,273 |
1,255 |
$384K |
| 93976 |
|
5,167 |
4,845 |
$383K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
1,713 |
1,639 |
$377K |
| G0379 |
Direct admission of patient for hospital observation care |
6,194 |
5,029 |
$375K |
| 93971 |
|
1,179 |
1,109 |
$370K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
2,278 |
1,763 |
$361K |
| 93975 |
|
1,446 |
1,352 |
$351K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
3,065 |
2,800 |
$349K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
3,056 |
2,847 |
$336K |
| 94727 |
|
2,388 |
2,184 |
$312K |
| 76813 |
|
2,135 |
2,112 |
$305K |
| 93242 |
|
759 |
737 |
$302K |
| J0585 |
Injection, onabotulinumtoxina, 1 unit |
433 |
431 |
$289K |
| 90847 |
Family psychotherapy with the patient present, 50 minutes |
4,794 |
3,396 |
$285K |
| 77412 |
|
1,069 |
119 |
$282K |
| 80061 |
Lipid panel |
12,167 |
11,424 |
$282K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
3,447 |
3,275 |
$281K |
| 77066 |
Tomosynthesis, mammo |
1,879 |
1,800 |
$275K |
| 90792 |
Psychiatric diagnostic evaluation with medical services |
3,759 |
3,618 |
$275K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
2,017 |
1,938 |
$275K |
| 99215 |
Prolong outpt/office vis |
2,567 |
2,275 |
$270K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
1,974 |
1,823 |
$269K |
| 87536 |
|
2,792 |
2,660 |
$267K |
| 73630 |
|
5,230 |
4,916 |
$265K |
| 73562 |
|
4,401 |
4,169 |
$265K |
| 96411 |
|
594 |
374 |
$258K |
| 77065 |
Tomosynthesis, mammo |
2,711 |
2,481 |
$255K |
| 73030 |
|
3,901 |
3,652 |
$255K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
19,860 |
19,078 |
$248K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
12,003 |
10,283 |
$246K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
5,769 |
5,621 |
$242K |
| 77080 |
|
2,251 |
2,185 |
$237K |
| 97010 |
|
11,946 |
3,922 |
$232K |
| 83655 |
|
4,522 |
4,463 |
$232K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
5,042 |
4,745 |
$218K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
8,704 |
8,308 |
$209K |
| 84443 |
Thyroid stimulating hormone (TSH) |
16,006 |
14,479 |
$209K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
4,552 |
4,334 |
$194K |
| 97803 |
|
2,261 |
1,921 |
$184K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
3,533 |
3,390 |
$183K |
| 93312 |
|
235 |
213 |
$181K |
| 93350 |
|
508 |
507 |
$181K |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
3,611 |
3,512 |
$177K |
| G0108 |
Diabetes outpatient self-management training services, individual, per 30 minutes |
1,030 |
756 |
$174K |
| 73130 |
|
3,761 |
3,574 |
$172K |
| 86900 |
|
23,743 |
20,848 |
$171K |
| J0897 |
Injection, denosumab, 1 mg |
109 |
90 |
$170K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
15,112 |
14,137 |
$166K |
| 88307 |
|
1,611 |
1,273 |
$165K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
4,434 |
4,232 |
$163K |
| 73610 |
|
4,255 |
3,999 |
$160K |
| 76536 |
|
1,255 |
1,176 |
$158K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
7,104 |
6,548 |
$153K |
| 99205 |
Prolong outpt/office vis |
1,397 |
1,275 |
$153K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
168 |
156 |
$149K |
| 73590 |
|
3,088 |
2,857 |
$147K |
| 85027 |
|
26,855 |
22,609 |
$144K |
| 80197 |
|
5,224 |
3,259 |
$140K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
10,925 |
10,253 |
$140K |
| 93225 |
|
212 |
212 |
$140K |
| S9484 |
Crisis intervention mental health services, per hour |
390 |
373 |
$139K |
| 69210 |
|
408 |
387 |
$138K |
| 59025 |
Fetal non-stress test |
892 |
667 |
$137K |
| 72110 |
|
1,652 |
1,588 |
$135K |
| 83880 |
|
16,947 |
14,513 |
$135K |
| 83021 |
|
4,699 |
4,118 |
$129K |
| 96376 |
|
8,341 |
6,127 |
$128K |
| 76870 |
|
1,138 |
1,102 |
$126K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
2,730 |
2,679 |
$126K |
| 64642 |
|
55 |
55 |
$124K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
3,351 |
2,888 |
$123K |
| 73110 |
|
2,241 |
2,113 |
$121K |
| C9290 |
Injection, bupivacaine liposome, 1 mg |
1,202 |
1,096 |
$119K |
| 76821 |
|
654 |
368 |
$119K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
8,153 |
7,839 |
$118K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
2,751 |
2,604 |
$118K |
| 93923 |
|
349 |
324 |
$116K |
| 88342 |
|
5,650 |
5,037 |
$115K |
| 85610 |
|
36,477 |
31,676 |
$115K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
913 |
833 |
$114K |
| 83735 |
|
35,822 |
29,431 |
$113K |
| 86360 |
|
2,695 |
2,575 |
$112K |
| 93886 |
|
154 |
153 |
$112K |
| 88142 |
|
2,761 |
2,717 |
$111K |
| 97162 |
|
2,813 |
2,478 |
$110K |
| 97802 |
|
920 |
897 |
$109K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
1,952 |
1,745 |
$106K |
| 74018 |
|
2,336 |
2,234 |
$103K |
| 93798 |
|
1,179 |
192 |
$102K |
| 82728 |
|
6,616 |
5,938 |
$102K |
| 81001 |
|
25,926 |
23,451 |
$101K |
| G0109 |
Diabetes outpatient self-management training services, group session (2 or more), per 30 minutes |
322 |
294 |
$100K |
| 77336 |
|
705 |
288 |
$100K |
| 96401 |
|
710 |
422 |
$100K |
| 71271 |
|
525 |
508 |
$97K |
| 85007 |
|
16,860 |
13,678 |
$97K |
| 90677 |
|
2,793 |
2,649 |
$97K |
| 70486 |
|
999 |
969 |
$96K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
264 |
252 |
$95K |
| 86359 |
|
2,695 |
2,575 |
$95K |
| 97161 |
|
2,436 |
2,316 |
$93K |
| 87081 |
|
3,064 |
3,035 |
$92K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
1,087 |
425 |
$92K |
| 81003 |
|
16,411 |
15,221 |
$92K |
| 86901 |
|
23,818 |
20,841 |
$90K |
| G0399 |
Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation |
140 |
136 |
$89K |
| 84484 |
|
26,465 |
21,672 |
$88K |
| 74022 |
|
1,216 |
1,171 |
$87K |
| 81025 |
|
12,206 |
10,680 |
$86K |
| 87070 |
|
3,889 |
3,489 |
$86K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
5,439 |
4,783 |
$86K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,797 |
1,739 |
$86K |
| 86592 |
|
7,423 |
7,095 |
$83K |
| 87340 |
|
22,616 |
18,690 |
$83K |
| 93304 |
|
181 |
171 |
$83K |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
1,264 |
1,038 |
$81K |
| 19083 |
|
55 |
50 |
$81K |
| 86922 |
|
1,499 |
1,168 |
$80K |
| 84439 |
|
8,488 |
7,558 |
$80K |
| 86336 |
|
999 |
983 |
$79K |
| 82247 |
|
4,015 |
3,409 |
$77K |
| 93321 |
|
229 |
210 |
$76K |
| 73090 |
|
2,135 |
1,995 |
$75K |
| 86480 |
|
1,559 |
1,484 |
$74K |
| 86355 |
|
2,695 |
2,575 |
$73K |
| 54150 |
|
26 |
26 |
$72K |
| 84702 |
|
9,168 |
7,593 |
$72K |
| 87040 |
|
5,236 |
4,740 |
$71K |
| 86902 |
|
1,575 |
1,263 |
$71K |
| 94726 |
|
495 |
486 |
$70K |
| 72100 |
|
1,224 |
1,178 |
$69K |
| C8929 |
Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography |
403 |
310 |
$69K |
| 85730 |
|
30,587 |
27,032 |
$68K |
| 86357 |
|
2,694 |
2,574 |
$67K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
1,788 |
874 |
$67K |
| 95806 |
|
193 |
182 |
$63K |
| 73560 |
|
1,493 |
1,412 |
$61K |
| J2785 |
Injection, regadenoson, 0.1 mg |
1,053 |
903 |
$59K |
| D7140 |
Extraction, erupted tooth or exposed root |
1,816 |
1,032 |
$55K |
| 10060 |
|
830 |
765 |
$55K |
| 84100 |
|
18,554 |
15,237 |
$54K |
| 73502 |
|
1,580 |
1,469 |
$54K |
| 85347 |
|
1,466 |
1,224 |
$54K |
| G0008 |
Administration of influenza virus vaccine |
4,684 |
4,491 |
$53K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
5,950 |
5,573 |
$52K |
| 36600 |
|
877 |
795 |
$51K |
| 73521 |
|
1,027 |
966 |
$51K |
| 87799 |
|
1,116 |
837 |
$50K |
| 36591 |
|
1,694 |
1,168 |
$50K |
| 86923 |
|
1,361 |
1,169 |
$50K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
24,220 |
19,344 |
$49K |
| 82542 |
|
2,147 |
2,103 |
$48K |
| 73060 |
|
1,024 |
955 |
$48K |
| J0561 |
Injection, penicillin g benzathine, 100,000 units |
873 |
841 |
$47K |
| 73564 |
|
694 |
661 |
$47K |
| 88341 |
|
1,724 |
1,354 |
$47K |
| 0296T |
|
217 |
217 |
$45K |
| 93243 |
|
209 |
200 |
$45K |
| A9552 |
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries |
621 |
547 |
$45K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
2,238 |
2,114 |
$45K |
| 82248 |
|
5,960 |
5,039 |
$45K |
| 82803 |
|
2,514 |
2,223 |
$44K |
| 76937 |
|
418 |
386 |
$43K |
| A9270 |
Non-covered item or service |
25,286 |
15,960 |
$42K |
| D0140 |
Limited oral evaluation - problem focused |
2,757 |
2,635 |
$42K |
| 93880 |
|
101 |
87 |
$41K |
| 83615 |
|
8,343 |
7,073 |
$41K |
| 87497 |
|
598 |
377 |
$40K |
| C1769 |
Guide wire |
3,367 |
2,910 |
$40K |
| 86300 |
|
1,560 |
1,367 |
$38K |
| J1439 |
Injection, ferric carboxymaltose, 1 mg |
54 |
36 |
$37K |
| 36416 |
|
1,871 |
1,779 |
$37K |
| 87186 |
|
2,640 |
2,333 |
$37K |
| P9040 |
Red blood cells, leukocytes reduced, irradiated, each unit |
164 |
132 |
$36K |
| 82805 |
|
1,108 |
963 |
$36K |
| S2900 |
Surgical techniques requiring use of robotic surgical system (list separately in addition to code for primary procedure) |
71 |
71 |
$35K |
| J2704 |
Injection, propofol, 10 mg |
19,572 |
17,679 |
$34K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
10,079 |
8,440 |
$34K |
| 73140 |
|
556 |
537 |
$33K |
| 73552 |
|
1,265 |
1,170 |
$33K |
| C1887 |
Catheter, guiding (may include infusion/perfusion capability) |
3,060 |
2,628 |
$33K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
8,980 |
7,946 |
$33K |
| 82607 |
|
2,989 |
2,773 |
$33K |
| 12001 |
|
636 |
591 |
$33K |
| 12011 |
|
628 |
595 |
$33K |
| 83550 |
|
4,149 |
3,826 |
$33K |
| 81401 |
|
826 |
800 |
$32K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
21,866 |
19,030 |
$32K |
| 85045 |
|
10,686 |
8,803 |
$32K |
| 82950 |
|
1,352 |
1,276 |
$31K |
| 83690 |
|
19,453 |
17,276 |
$31K |
| Q3014 |
Telehealth originating site facility fee |
5,904 |
5,264 |
$31K |
| 86828 |
|
704 |
506 |
$31K |
| 86803 |
|
4,174 |
3,850 |
$31K |
| 64640 |
|
13 |
13 |
$30K |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
4,819 |
4,013 |
$30K |
| 86704 |
|
1,831 |
1,667 |
$30K |
| 73080 |
|
843 |
803 |
$29K |
| 87210 |
|
5,066 |
4,975 |
$29K |
| C1760 |
Closure device, vascular (implantable/insertable) |
1,173 |
1,010 |
$29K |
| 70491 |
|
221 |
209 |
$29K |
| 88304 |
|
2,723 |
2,590 |
$28K |
| 83540 |
|
4,387 |
4,046 |
$28K |
| 85055 |
|
1,324 |
893 |
$28K |
| C1725 |
Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) |
835 |
720 |
$28K |
| D0150 |
Comprehensive oral evaluation - new or established patient |
1,235 |
1,215 |
$28K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
907 |
331 |
$27K |
| 76641 |
|
84 |
75 |
$27K |
| 82043 |
|
2,283 |
2,190 |
$26K |
| C1889 |
Implantable/insertable device, not otherwise classified |
204 |
185 |
$26K |
| 85384 |
|
2,503 |
2,191 |
$26K |
| 73120 |
|
555 |
532 |
$25K |
| 75561 |
|
43 |
41 |
$25K |
| 86920 |
|
500 |
481 |
$25K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
4,479 |
4,284 |
$25K |
| 81243 |
|
706 |
682 |
$25K |
| 93505 |
|
18 |
14 |
$25K |
| 90715 |
|
3,972 |
3,797 |
$24K |
| 74174 |
|
138 |
124 |
$24K |
| 95700 |
|
404 |
373 |
$23K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
724 |
674 |
$23K |
| 96402 |
|
210 |
190 |
$22K |
| 82746 |
|
2,244 |
2,063 |
$22K |
| 97116 |
|
1,378 |
923 |
$22K |
| 96450 |
|
32 |
25 |
$20K |
| 97164 |
|
678 |
594 |
$20K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
17,548 |
16,147 |
$20K |
| D1206 |
Topical application of fluoride varnish |
1,354 |
1,342 |
$20K |
| 73620 |
|
450 |
435 |
$20K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
32,617 |
28,460 |
$20K |
| 73600 |
|
777 |
730 |
$20K |
| 77334 |
|
34 |
27 |
$19K |
| 92582 |
|
67 |
66 |
$19K |
| 93308 |
|
155 |
133 |
$19K |
| 29581 |
|
144 |
84 |
$19K |
| 87400 |
|
1,578 |
1,563 |
$19K |
| J1453 |
Injection, fosaprepitant, 1 mg |
397 |
209 |
$19K |
| 73070 |
|
633 |
593 |
$18K |
| 87147 |
|
1,367 |
1,335 |
$18K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
6,801 |
4,890 |
$18K |
| 87077 |
|
2,384 |
2,197 |
$18K |
| 73100 |
|
604 |
573 |
$18K |
| 87428 |
|
498 |
468 |
$18K |
| D1120 |
Prophylaxis - child |
1,306 |
1,288 |
$18K |
| 76942 |
|
642 |
629 |
$18K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
10,107 |
8,614 |
$18K |
| 90853 |
Group psychotherapy (other than of a multiple-family group) |
481 |
210 |
$17K |
| G0009 |
Administration of pneumococcal vaccine |
2,853 |
2,710 |
$17K |
| 42830 |
|
13 |
12 |
$16K |
| 77290 |
|
49 |
41 |
$16K |
| D0210 |
Intraoral - complete series of radiographic images |
647 |
643 |
$16K |
| 81002 |
|
3,925 |
2,722 |
$16K |
| 90674 |
|
2,696 |
2,560 |
$16K |
| 82570 |
|
2,842 |
2,493 |
$16K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
542 |
512 |
$15K |
| 84156 |
|
2,905 |
2,466 |
$15K |
| 86708 |
|
1,054 |
992 |
$15K |
| 93925 |
|
32 |
32 |
$14K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
296 |
289 |
$14K |
| 76885 |
|
85 |
84 |
$13K |
| 84550 |
|
3,425 |
2,992 |
$13K |
| 77417 |
|
106 |
50 |
$13K |
| 86762 |
|
1,735 |
1,705 |
$13K |
| 76775 |
|
101 |
97 |
$12K |
| 87522 |
Neg quan hep c or qual rna |
373 |
333 |
$12K |
| 85651 |
|
4,647 |
4,296 |
$12K |
| C1874 |
Stent, coated/covered, with delivery system |
44 |
24 |
$12K |
| J1631 |
Injection, haloperidol decanoate, per 50 mg |
648 |
548 |
$12K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
8,965 |
7,094 |
$12K |
| 17250 |
|
53 |
50 |
$11K |
| 83605 |
|
3,743 |
3,268 |
$11K |
| 86140 |
|
4,655 |
4,329 |
$11K |
| D1110 |
Prophylaxis - adult |
722 |
718 |
$11K |
| 0001A |
|
334 |
331 |
$11K |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
1,162 |
716 |
$11K |
| 95711 |
|
59 |
57 |
$11K |
| G0123 |
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision |
577 |
538 |
$11K |
| 92611 |
|
29 |
27 |
$11K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
5,117 |
4,495 |
$11K |
| 82378 |
|
846 |
667 |
$11K |
| J1644 |
Injection, heparin sodium, per 1000 units |
2,517 |
1,920 |
$10K |
| 87205 |
|
2,832 |
2,374 |
$10K |
| 87999 |
|
461 |
361 |
$10K |
| 87496 |
|
193 |
161 |
$10K |
| 84153 |
|
519 |
474 |
$10K |
| 76882 |
|
88 |
86 |
$10K |
| 85378 |
|
5,373 |
4,983 |
$10K |
| 92652 |
|
28 |
28 |
$10K |
| 88313 |
|
552 |
436 |
$10K |
| D0330 |
Panoramic radiographic image |
923 |
885 |
$9K |
| J1756 |
Injection, iron sucrose, 1 mg |
351 |
156 |
$9K |
| 86870 |
|
152 |
134 |
$9K |
| Q9957 |
Injection, perflutren lipid microspheres, per ml |
933 |
795 |
$9K |
| 0002A |
|
272 |
272 |
$9K |
| 87808 |
|
2,928 |
2,872 |
$9K |
| 86664 |
|
271 |
187 |
$9K |
| 87486 |
|
764 |
750 |
$9K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
2,133 |
1,790 |
$9K |
| 96368 |
|
452 |
359 |
$9K |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
7,127 |
6,295 |
$9K |
| 87088 |
|
4,012 |
3,802 |
$8K |
| J9370 |
Vincristine sulfate, 1 mg |
733 |
534 |
$8K |
| 77072 |
|
116 |
115 |
$8K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
5,044 |
3,672 |
$8K |
| 84480 |
|
659 |
615 |
$8K |
| 86039 |
|
421 |
392 |
$8K |
| A9577 |
Injection, gadobenate dimeglumine (multihance), per ml |
749 |
686 |
$8K |
| 85660 |
|
1,651 |
1,231 |
$7K |
| 72197 |
|
15 |
14 |
$7K |
| 86665 |
|
392 |
274 |
$7K |
| 84132 |
|
3,577 |
3,094 |
$7K |
| 86787 |
|
339 |
325 |
$7K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
6,451 |
5,997 |
$7K |
| 90785 |
|
132 |
115 |
$7K |
| 77086 |
|
164 |
164 |
$7K |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
399 |
381 |
$7K |
| 85240 |
|
252 |
223 |
$7K |
| D0120 |
Periodic oral evaluation - established patient |
461 |
461 |
$7K |
| D0220 |
Intraoral - periapical first radiographic image |
1,926 |
1,873 |
$7K |
| 93041 |
|
116 |
111 |
$6K |
| 98968 |
|
833 |
795 |
$6K |
| G0297 |
Low dose ct scan (ldct) for lung cancer screening |
13 |
13 |
$6K |
| 83020 |
|
844 |
585 |
$6K |
| 82270 |
|
1,260 |
1,179 |
$6K |
| 80076 |
|
509 |
465 |
$6K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
12 |
12 |
$6K |
| 90710 |
|
368 |
358 |
$6K |
| 87581 |
|
764 |
750 |
$6K |
| 83883 |
|
525 |
396 |
$6K |
| 89051 |
|
644 |
516 |
$6K |
| D2392 |
Resin-based composite - two surfaces, posterior, primary or permanent |
157 |
118 |
$6K |
| J2060 |
Injection, lorazepam, 2 mg |
1,462 |
1,188 |
$6K |
| 15853 |
|
193 |
177 |
$6K |
| A9579 |
Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml |
608 |
565 |
$6K |
| J1815 |
Injection, insulin, per 5 units |
1,740 |
1,379 |
$6K |
| 29125 |
|
191 |
172 |
$6K |
| 72081 |
|
52 |
51 |
$5K |
| 72050 |
|
110 |
109 |
$5K |
| J1630 |
Injection, haloperidol, up to 5 mg |
1,734 |
1,384 |
$5K |
| 87075 |
|
408 |
331 |
$5K |
| 74240 |
|
38 |
38 |
$5K |
| A9502 |
Technetium tc-99m tetrofosmin, diagnostic, per study dose |
327 |
270 |
$5K |
| 90651 |
|
509 |
488 |
$5K |
| D0145 |
Oral evaluation for a patient under three years of age |
353 |
352 |
$5K |
| G0010 |
Administration of hepatitis b vaccine |
256 |
250 |
$5K |
| 78306 |
|
33 |
28 |
$5K |
| 85380 |
|
720 |
664 |
$5K |
| C8930 |
Transthoracic echocardiography, with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, during rest and cardiovascular stress test using treadmill, bicycle exercise and/or pharmacologically induced stress, with interpretation and report; including performance of continuous electrocardiographic monitoring, with physician supervision |
12 |
12 |
$5K |
| 93922 |
|
39 |
39 |
$5K |
| 72040 |
|
65 |
60 |
$5K |
| 70498 |
|
27 |
26 |
$5K |
| 87150 |
|
280 |
261 |
$5K |
| J2469 |
Injection, palonosetron hcl, 25 mcg |
507 |
274 |
$5K |
| 84165 |
|
810 |
629 |
$5K |
| 90686 |
|
778 |
746 |
$5K |
| 84703 |
|
2,112 |
1,928 |
$5K |
| 82550 |
|
2,409 |
2,192 |
$4K |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
2,697 |
1,452 |
$4K |
| 82375 |
|
683 |
567 |
$4K |
| 83010 |
|
602 |
474 |
$4K |
| 86317 |
|
911 |
770 |
$4K |
| 88312 |
|
120 |
118 |
$4K |
| 74160 |
|
14 |
12 |
$4K |
| J3535 |
Drug administered through a metered dose inhaler |
1,690 |
1,367 |
$4K |
| 82784 |
|
277 |
225 |
$4K |
| 85018 |
|
3,338 |
2,835 |
$4K |
| G0103 |
Prostate cancer screening; prostate specific antigen test (psa) |
218 |
154 |
$4K |
| 72131 |
|
37 |
36 |
$4K |
| 80179 |
|
1,348 |
1,200 |
$4K |
| 84030 |
|
109 |
104 |
$4K |
| 98967 |
|
771 |
735 |
$4K |
| 72141 |
|
14 |
13 |
$4K |
| 72070 |
|
55 |
55 |
$4K |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
1,816 |
1,656 |
$4K |
| 84481 |
|
355 |
312 |
$3K |
| 77280 |
|
13 |
12 |
$3K |
| 86880 |
|
339 |
287 |
$3K |
| 20610 |
|
15 |
13 |
$3K |
| 93247 |
|
13 |
13 |
$3K |
| D0190 |
|
652 |
643 |
$3K |
| 82010 |
|
1,629 |
1,443 |
$3K |
| 86706 |
|
299 |
259 |
$3K |
| 12002 |
|
100 |
93 |
$3K |
| 87631 |
|
139 |
137 |
$3K |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
2,048 |
1,660 |
$3K |
| 86304 |
|
206 |
177 |
$3K |
| 80177 |
|
671 |
598 |
$2K |
| 87807 |
|
335 |
333 |
$2K |
| D7210 |
Extraction, erupted tooth requiring removal of bone and/or sectioning of tooth |
73 |
52 |
$2K |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
2,360 |
1,971 |
$2K |
| 82397 |
|
259 |
240 |
$2K |
| 80164 |
|
267 |
236 |
$2K |
| 84145 |
|
408 |
366 |
$2K |
| 86003 |
|
14 |
14 |
$2K |
| A9575 |
Injection, gadoterate meglumine, 0.1 ml |
469 |
420 |
$2K |
| 83001 |
|
59 |
51 |
$2K |
| 90739 |
|
40 |
39 |
$2K |
| OP637 |
|
3,687 |
2,119 |
$2K |
| 99201 |
|
27 |
26 |
$2K |
| 84146 |
|
46 |
38 |
$2K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
46 |
44 |
$2K |
| 74230 |
|
30 |
27 |
$2K |
| D0274 |
Bitewings - four radiographic images |
249 |
247 |
$2K |
| 90381 |
|
14 |
14 |
$2K |
| 83050 |
|
652 |
539 |
$2K |
| 82533 |
|
139 |
93 |
$2K |
| C1751 |
Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis) |
85 |
80 |
$2K |
| A4648 |
Tissue marker, implantable, any type, each |
61 |
55 |
$2K |
| 87517 |
|
39 |
27 |
$2K |
| 64488 |
|
31 |
25 |
$2K |
| J9267 |
Injection, paclitaxel, 1 mg |
110 |
39 |
$2K |
| 85041 |
|
2,035 |
1,674 |
$2K |
| 85245 |
|
39 |
36 |
$2K |
| 86790 |
|
41 |
41 |
$2K |
| 82024 |
|
58 |
38 |
$2K |
| 86334 |
|
241 |
174 |
$2K |
| 86705 |
|
179 |
150 |
$2K |
| 85014 |
|
2,072 |
1,702 |
$2K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
42 |
42 |
$1K |
| 97165 |
|
24 |
24 |
$1K |
| 90656 |
|
734 |
730 |
$1K |
| 87430 |
|
120 |
118 |
$1K |
| 92523 |
|
12 |
12 |
$1K |
| J1953 |
Injection, levetiracetam, 10 mg |
563 |
470 |
$1K |
| J0280 |
Injection, aminophyllin, up to 250 mg |
475 |
412 |
$1K |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
935 |
787 |
$1K |
| 73522 |
|
15 |
15 |
$1K |
| J3480 |
Injection, potassium chloride, per 2 meq |
1,221 |
899 |
$1K |
| 86780 |
|
267 |
253 |
$1K |
| 80143 |
|
289 |
261 |
$1K |
| 83520 |
|
41 |
36 |
$1K |
| 99381 |
|
12 |
12 |
$1K |
| 90716 |
|
710 |
675 |
$1K |
| 97014 |
|
73 |
25 |
$1K |
| M0222 |
Intravenous injection, bebtelovimab, includes injection and post administration monitoring |
17 |
15 |
$1K |
| L1830 |
Knee orthosis, immobilizer, canvas longitudinal, prefabricated, off-the-shelf |
58 |
58 |
$1K |
| 86431 |
|
118 |
112 |
$1K |
| 82985 |
|
82 |
72 |
$999.62 |
| 85652 |
|
680 |
614 |
$974.81 |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
603 |
529 |
$973.74 |
| 90673 |
|
149 |
147 |
$925.03 |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
491 |
406 |
$883.82 |
| 83521 |
|
87 |
72 |
$860.03 |
| 82977 |
|
69 |
69 |
$850.28 |
| 90620 |
|
109 |
108 |
$813.66 |
| 84436 |
|
275 |
244 |
$786.51 |
| 90380 |
|
12 |
12 |
$785.29 |
| 84466 |
|
99 |
78 |
$780.21 |
| 82330 |
|
152 |
141 |
$772.89 |
| 96377 |
|
22 |
12 |
$752.57 |
| J0134 |
Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg |
672 |
622 |
$747.94 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
262 |
254 |
$747.04 |
| 90682 |
|
71 |
70 |
$739.87 |
| 82140 |
|
375 |
323 |
$692.01 |
| G0257 |
Unscheduled or emergency dialysis treatment for an esrd patient in a hospital outpatient department that is not certified as an esrd facility |
210 |
67 |
$656.11 |
| 90734 |
|
425 |
406 |
$636.36 |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
158 |
103 |
$634.76 |
| D0270 |
|
209 |
208 |
$609.00 |
| D2391 |
Resin-based composite - one surface, posterior, primary or permanent |
20 |
12 |
$608.00 |
| 84134 |
|
54 |
39 |
$599.71 |
| J1940 |
Injection, furosemide, up to 20 mg |
958 |
663 |
$592.17 |
| 86160 |
|
39 |
39 |
$575.26 |
| 85246 |
|
28 |
26 |
$563.16 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
515 |
384 |
$562.67 |
| 96523 |
|
18 |
13 |
$560.45 |
| 90746 |
|
45 |
44 |
$540.67 |
| 36592 |
|
26 |
13 |
$539.76 |
| 0031A |
|
30 |
30 |
$526.30 |
| D0603 |
|
156 |
152 |
$500.00 |
| 29130 |
|
14 |
13 |
$442.12 |
| 88108 |
|
15 |
12 |
$437.62 |
| 77001 |
|
20 |
14 |
$431.82 |
| 85008 |
|
373 |
276 |
$431.54 |
| 86735 |
|
12 |
12 |
$419.13 |
| 84157 |
|
28 |
26 |
$406.22 |
| 88112 |
|
100 |
68 |
$371.51 |
| 82565 |
|
12 |
12 |
$347.00 |
| 98966 |
|
162 |
155 |
$344.61 |
| D0230 |
Intraoral - periapical each additional radiographic image |
179 |
103 |
$338.25 |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
476 |
460 |
$335.91 |
| 90697 |
|
1,648 |
1,572 |
$322.53 |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
461 |
367 |
$317.38 |
| 83930 |
|
146 |
119 |
$311.62 |
| 86038 |
|
19 |
16 |
$302.79 |
| D0601 |
|
39 |
39 |
$300.00 |
| 82150 |
|
85 |
80 |
$293.61 |
| D1208 |
Topical application of fluoride, excluding varnish |
29 |
29 |
$290.00 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
901 |
843 |
$288.02 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
575 |
567 |
$287.31 |
| 90696 |
|
336 |
322 |
$286.01 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
130 |
120 |
$281.46 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
284 |
253 |
$272.91 |
| 90633 |
|
1,262 |
1,197 |
$248.99 |
| 86644 |
|
30 |
24 |
$247.84 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
598 |
576 |
$234.31 |
| 82274 |
|
87 |
70 |
$231.09 |
| OP255 |
|
208 |
189 |
$230.09 |
| 90662 |
|
104 |
100 |
$222.42 |
| 90681 |
|
1,100 |
1,047 |
$222.04 |
| A9561 |
Technetium tc-99m oxidronate, diagnostic, per study dose, up to 30 millicuries |
35 |
28 |
$217.11 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
64 |
60 |
$216.06 |
| 90750 |
|
16 |
15 |
$215.62 |
| 90707 |
|
692 |
657 |
$210.87 |
| 80185 |
|
14 |
12 |
$203.85 |
| 80320 |
|
159 |
147 |
$203.55 |
| 90700 |
|
592 |
559 |
$189.84 |
| 82785 |
|
30 |
25 |
$169.44 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
2,129 |
1,879 |
$162.94 |
| 82945 |
|
15 |
15 |
$160.13 |
| 87101 |
|
36 |
24 |
$154.83 |
| J1596 |
Injection, glycopyrrolate, 0.1 mg |
455 |
419 |
$136.03 |
| 84154 |
|
16 |
13 |
$128.38 |
| 90744 |
|
16 |
16 |
$119.60 |
| 95873 |
|
12 |
12 |
$115.32 |
| J2371 |
Injection, phenylephrine hydrochloride, 20 micrograms |
279 |
231 |
$103.12 |
| 82668 |
|
15 |
12 |
$102.73 |
| J0461 |
Injection, atropine sulfate, 0.01 mg |
15 |
12 |
$101.93 |
| J1250 |
Injection, dobutamine hydrochloride, per 250 mg |
12 |
12 |
$97.65 |
| 80329 |
|
82 |
78 |
$90.97 |
| J1643 |
Injection, heparin sodium (pfizer), not therapeutically equivalent to j1644, per 1000 units |
397 |
293 |
$87.23 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
358 |
325 |
$72.49 |
| J2310 |
Injection, naloxone hydrochloride, per 1 mg |
39 |
28 |
$71.59 |
| J7510 |
Prednisolone oral, per 5 mg |
68 |
68 |
$69.45 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
176 |
105 |
$68.89 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
162 |
133 |
$67.96 |
| Q0144 |
Azithromycin dihydrate, oral, capsules/powder, 1 gram |
230 |
230 |
$66.11 |
| C1884 |
Embolization protective system |
13 |
13 |
$64.46 |
| D0602 |
|
17 |
14 |
$60.00 |
| 86141 |
|
30 |
26 |
$59.35 |
| 87102 |
|
82 |
52 |
$55.84 |
| D0272 |
Bitewings - two radiographic images |
12 |
12 |
$55.00 |
| 90648 |
|
507 |
480 |
$50.65 |
| 87493 |
|
14 |
14 |
$44.29 |
| 90698 |
|
195 |
182 |
$40.03 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
152 |
122 |
$35.93 |
| J0692 |
Injection, cefepime hydrochloride, 500 mg |
14 |
13 |
$29.74 |
| J0737 |
Injection, clindamycin phosphate (baxter), not therapeutically equivalent to j0736, 300 mg |
38 |
31 |
$28.01 |
| G8985 |
Carrying, moving and handling objects, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
25 |
24 |
$27.00 |
| 84520 |
|
47 |
39 |
$24.25 |
| J1790 |
Injection, droperidol, up to 5 mg |
30 |
28 |
$18.81 |
| 85460 |
|
13 |
13 |
$18.80 |
| J0136 |
Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg |
16 |
15 |
$18.00 |
| J7121 |
5% dextrose in lactated ringers infusion, up to 1000 cc |
15 |
13 |
$16.52 |
| J2471 |
Injection, pantoprazole (hikma), not therapeutically equivalent to j2470, 40 mg |
44 |
36 |
$15.51 |
| G0472 |
Hepatitis c antibody screening, for individual at high risk and other covered indication(s) |
16 |
12 |
$13.79 |
| J2004 |
Injection, lidocaine hcl with epinephrine, 1 mg |
24 |
22 |
$11.95 |
| J0687 |
Injection, cefazolin sodium (wg critical care), not therapeutically equivalent to j0690, 500 mg |
227 |
214 |
$11.03 |
| J2470 |
Injection, pantoprazole sodium, 40 mg |
37 |
34 |
$8.97 |
| J0736 |
Injection, clindamycin phosphate, 300 mg |
14 |
12 |
$7.06 |
| Q0244 |
Injection, casirivimab and imdevimab, 1200 mg |
27 |
26 |
$7.00 |
| 91303 |
|
17 |
17 |
$6.00 |
| 86225 |
|
13 |
13 |
$3.33 |
| Q0245 |
Injection, bamlanivimab and etesevimab, 2100 mg |
15 |
14 |
$3.00 |
| Q0222 |
Injection, bebtelovimab, 175 mg |
17 |
15 |
$2.00 |
| J0401 |
Injection, aripiprazole (abilify maintena), 1 mg |
13 |
12 |
$1.00 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
27 |
27 |
$0.00 |
| D1330 |
|
189 |
184 |
$0.00 |
| C1753 |
Catheter, intravascular ultrasound |
12 |
12 |
$0.00 |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
38 |
38 |
$0.00 |
| M0244 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency |
19 |
19 |
$0.00 |
| 91300 |
|
524 |
443 |
$0.00 |